TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Evolan Pharma AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
66,220
|
65,385
|
54,138 |
| Financial expenses |
158
|
132
|
355 |
| Earnings before taxes |
21,017
|
19,061
|
12,157 |
| EBITDA |
27,554
|
25,915
|
18,957 |
| Total assets |
77,592
|
54,003
|
41,901 |
| Current assets |
44,226
|
34,599
|
24,895 |
| Current liabilities |
19,208
|
14,967
|
14,987 |
| Equity capital |
47,401
|
35,762
|
22,640 |
| - share capital |
9
|
10
|
10 |
| Employees (average) |
27
|
27
|
27 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
61.1%
|
66.2%
|
54.0% |
| Turnover per employee |
2,453
|
2,422
|
2,005 |
| Profit as a percentage of turnover |
31.7%
|
29.2%
|
22.5% |
| Return on assets (ROA) |
27.3%
|
35.5%
|
29.9% |
| Current ratio |
230.2%
|
231.2%
|
166.1% |
| Return on equity (ROE) |
44.3%
|
53.3%
|
53.7% |
| Change turnover |
6,132
|
12,249
|
10,260 |
| Change turnover % |
10%
|
23%
|
23% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
4% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.